496 related articles for article (PubMed ID: 27938677)
1. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
[TBL] [Abstract][Full Text] [Related]
2. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
Tabynov K; Ryskeldinova S; Sansyzbay A
Vaccine; 2015 Jul; 33(31):3619-23. PubMed ID: 26093199
[TBL] [Abstract][Full Text] [Related]
3. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev. 1.
al-Khalaf SA; Mohamad BT; Nicoletti P
Trop Anim Health Prod; 1992 Feb; 24(1):45-9. PubMed ID: 1306918
[TBL] [Abstract][Full Text] [Related]
4. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
[TBL] [Abstract][Full Text] [Related]
5. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
[TBL] [Abstract][Full Text] [Related]
6. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
7. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
Blasco JM
Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
[TBL] [Abstract][Full Text] [Related]
9. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
Díaz-Aparicio E; Hernández L; Suárez-Güemes F
Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep.
Pérez-Sancho M; Adone R; García-Seco T; Tarantino M; Diez-Guerrier A; Drumo R; Francia M; Domínguez L; Pasquali P; Álvarez J
Vaccine; 2014 Apr; 32(16):1877-81. PubMed ID: 24508034
[TBL] [Abstract][Full Text] [Related]
11. Control and eradication of Brucella melitensis infection in sheep and goats.
Blasco JM; Molina-Flores B
Vet Clin North Am Food Anim Pract; 2011 Mar; 27(1):95-104. PubMed ID: 21215893
[TBL] [Abstract][Full Text] [Related]
12. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
[TBL] [Abstract][Full Text] [Related]
13. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya.
Mustafa AA; Abusowa M
Vet Res; 1993; 24(5):422-9. PubMed ID: 8260964
[TBL] [Abstract][Full Text] [Related]
14. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.
Tabynov K; Yespembetov B; Sansyzbay A
Vaccine; 2014 Oct; 32(45):5889-92. PubMed ID: 25218295
[TBL] [Abstract][Full Text] [Related]
15. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity of Brucella abortus and Brucella melitensis in Kazakhstan using MLVA-16.
Shevtsov A; Ramanculov E; Shevtsova E; Kairzhanova A; Tarlykov P; Filipenko M; Dymova M; Abisheva G; Jailbekova A; Kamalova D; Chsherbakov A; Tulegenov S; Akhmetova A; Sytnik I; Karibaev T; Mukanov K
Infect Genet Evol; 2015 Aug; 34():173-80. PubMed ID: 26160544
[TBL] [Abstract][Full Text] [Related]
19. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
20. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
